Protein Biomarkers of Gastric Preneoplasia and Cancer Lesions in Blood: A Comprehensive Review
Preprint
- 30 July 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Gastric cancer (GC) is a major cause of cancer-related mortality worldwide, often associated with a bad prognosis because of its asymptomatic phenotype until advanced stages, highlighting the need for its prevention and early detection. GC development is preceded by gastric preneoplasia lesions (GPNL), namely atrophic gastritis (AG), intestinal metaplasia (IM), and dysplasia (DYS). GC is currently diagnosed by endoscopy, which is invasive and costly and has limited effectiveness for the detection of GPNL. Therefore, the discovery of non-invasive biomarkers in liquid biopsies, such as blood samples, to identify the presence of gastric preneoplasia and/or cancer lesions at an asymptomatic stage, is of paramount interest. This comprehensive review provides an overview of plasma/serum proteins recently identified and their diagnostic performance for the prediction of GPNL and early cancer lesions. Autoantibodies appear as promising biomarkers for AG, IM and early gastric cancer detection, along with inflammation and immunity-related proteins and antibodies against H. pylori virulence factors. There is a lack of specific protein biomarkers to detect DYS. Despite the need for further investigation and validation, some emerging candidates could pave the way to develop reliable, non-invasive diagnostic tests for the detection and prevention of GC.Keywords
All Related Versions
This publication has 111 references indexed in Scilit:
- Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesionJournal of Cancer Research and Clinical Oncology, 2023
- Identification of anti-Helicobacter pylori antibody signatures in gastric intestinal metaplasiaJournal of Gastroenterology, 2022
- The diagnostic value of serum gastrokine 1 (GKN1) protein in gastric cancerCancer Medicine, 2019
- Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discoveryAnalytical and Bioanalytical Chemistry, 2017
- Discovery of gastric cancer specific biomarkers by the application of serum proteomicsProteomics, 2017
- Global burden of gastric cancer attributable toHelicobacterpyloriInternational Journal of Cancer, 2014
- Gastritis staging: interobserver agreement by applying OLGA and OLGIM systemsVirchows Archiv, 2014
- Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese populationInternational Journal of Cancer, 2013
- Gastrokine 1 regulates NF‐κB signaling pathway and cytokine expression in gastric cancersJournal of Cellular Biochemistry, 2013
- Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non‐neoplastic gastric tissuesThe Journal of Pathology, 2002